Overactive bladder: Evaluation and management in primary care

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 2, 2005, Pages 149-156

  Rosenberg, Matt T ^a   Dmochowski, Roger R ^b  

^a Mid Michigan Health Centers Jackson   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CAFFEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; ESTROGEN; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; NARCOTIC AGENT; OXYBUTYNIN; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; BENZHYDRYL DERIVATIVE; CRESOL; MANDELIC ACID DERIVATIVE; PHENYLPROPANOLAMINE;

ABDOMINAL PRESSURE; ALCOHOL CONSUMPTION; ALGORITHM; BEHAVIOR THERAPY; BLADDER SURGERY; CLINICAL TRIAL; COFFEE; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; COST OF ILLNESS; DELIRIUM; DEPRESSION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERABILITY; ELDERLY CARE; FALLING; FECES IMPACTION; FRACTURE; HERNIA; HIGH RISK PATIENT; HUMAN; IMMOBILIZATION; LIFESTYLE; LITHOTOMY; LUMBAR DISK HERNIA; MEDICAL CARE; MIXED INCONTINENCE; NEUROGENIC BLADDER; NEUROLOGIC EXAMINATION; OVERACTIVE BLADDER; PATIENT REFERRAL; PELVIS FLOOR; PHYSICAL EXAMINATION; PHYSICAL STRESS; PHYSIOTHERAPY; PREVALENCE; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL DYSFUNCTION; SKIN IRRITATION; SKIN ULCER; SLEEP DISORDER; SOCIAL ISOLATION; STRESS INCONTINENCE; STROKE; SUSTAINED RELEASE FORMULATION; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TRANSDERMAL PATCH; URETHRA FUNCTION; URINALYSIS; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS; VAGINA ATROPHY; VAGINAL DELIVERY; VAGINAL HYSTERECTOMY; VALSALVA MANEUVER; WORK DISABILITY; XEROSTOMIA; METHODOLOGY; STANDARD;

ALGORITHMS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZHYDRYL COMPOUNDS; CHOLINERGIC ANTAGONISTS; CRESOLS; HUMANS; IMIPRAMINE; MANDELIC ACIDS; PHENYLPROPANOLAMINE; PRIMARY HEALTH CARE; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS;

EID: 17844376515     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.2.149     Document Type: Review

References (43)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002; 187:116-126.
2. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20:327-336.
3. Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology 2002; 60(suppl 5A):7-12.
4. Wagner TH, Hu TW. Economic costs of urinary incontinence in 1995. Urology 1998; 51:355-361.
5. Wilson L, Brown JS, Shin GP, Luc K-O, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol 2001; 98:398-406.
6. Brown JS, McGhan WF, Chokroverty S. Comorbidities associated with overactive bladder. Am J Manag Care 2000; 6:S574-S579.
7. Couture JA, Valiquette L. Urinary incontinence. Ann Pharmacother 2000; 34:646-655.
8. Dugan E, Cohen SJ, Bland DR, et al. The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc 2000; 48:413-416.
9. Liberman JN, Hunt TL, Stewart WF, et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a US community-based survey. Urology 2001; 57:1044-1050.
10. Burgio KL, Ives DG, Locher JL, Arena VC, Kuller LH. Treatment seeking for urinary incontinence in older adults. J Am Geriatr Soc 1994; 42:208-212.
11. Dugan E, Roberts CP, Cohen SJ, et al. Why older community-dwelling adults do not discuss urinary incontinence with their primary care physicians. J Am Geriatr Soc 2001; 49:462-465.
12. Culligan PJ, Heit M. Urinary incontinence in women: evaluation and management. Am Fam Physician 2000; 62:2433-2444.
13. Fantl JA, Kaschak-Newman D, Colling J, et al. Managing acute and chronic urinary incontinence. Clinical Practice Guideline Update. Quick Reference Guide for Clinicians, No. 2, 1996 Update. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Pub. No. 96-0686. November 1996.
14. Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 2003; 110:247-254.
15. Weiss BD. Diagnostic evaluation of urinary incontinence in geriatric patients. Am Fam Physician 1998; 57:2675-2690.
16. Dwyer PL, Rosamilia A. Evaluation and diagnosis of the overactive bladder. Clin Obstet Gynecol 2002; 45:193-204.
17. Handa VL, Jensen JK, Ostergard DR. The effect of patient position on proximal urethral mobility. Obstet Gynecol 1995; 86:273-276.
18. Pollak JT, Jenkins P, Kopka SL, Davila GW. Effect of genital prolapse on assessment of bladder neck mobility by the Q-tip test. Obstet Gynecol 2003; 101:662-665.
19. Marinkovic SP, Stanton SL. Incontinence and voiding difficulties associated with prolapse. J Urol 2004; 171:1021-1028.
20. Kobashi KC, Leach GE. Pelvic prolapse. J Urol 2000; 164:1879-1890.
21. Fantl JA, Kaschak-Newman D, Colling J, et al. Urinary incontinence in adults: acute and chronic management. Clinical practice guideline No. 2, 1996 Update. Rockville, MD: US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0682. March 1996.
22. Berghmans LC, Hendriks HJ, De Bie RA, van Waalwijk van Doorn ES, van Kerrebroeck PE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. BJU Int 2000; 85:254-263.
23. Bump RC, Hurt WG, Fantl JA, Wyman JF. Assessment of Kegel pelvic muscle exercise performance after brief verbal instruction. Am J Obstet Gynecol 1991; 165:322-327.
24. Resnick NM, Griffiths DJ. Expanding treatment options for stress urinary incontinence in women. JAMA 2003; 290:395-397.
25. Burgio KL, Goode PS, Locher JL, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA 2002; 288:2293-2299.
26. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 2000; 48:370-374.
27. Mattiasson A, Blaakaer J, Hoye K, Wein AJ. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 2003; 91:54-60.
28. Thakar R, Stanton S. Regular review: management of urinary incontinence in women. BMJ 2000; 321:1326-1331.
29. Wein AJ, Rovner ES. Pharmacologic management of urinary incontinence in women. Urol Clin North Am 2002; 29:537-550.
30. Cannon TW, Chancellor MB. Pharmacotherapy of the overactive bladder and advances in drug delivery. Clin Obstet Gynecol 2002; 45:205-217.
31. Yoshimura N, Chancellor MB. Current and future pharmacological treatment for overactive bladder. J Urol 2002; 168:1897-1913.
32. Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003; 326:841-847.
33. Drake MJ, Nixon PM, Crew JP. Drug-induced bladder and urinary disorders: incidence, prevention, and management. Drug Saf 1998; 19:45-55.
34. Rovner ES, Wein AJ. The treatment of overactive bladder in the geriatric patient. Clin Geriatrics 2002; 10:1-12.
35. Diokno AC, Appell RA, Sand PK, et al. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc 2003; 78:687-695.
36. Anderson RU, Mobley D, Blank B, Sultzstein D, Susset J, Brown JS; for the OROS Oxybutynin Study Group. Once daily controlled vs immediate release oxybutynin chloride for urge urinary incontinence. J Urol 1999; 161:1809-1812.
37. Physicians' Desk Reference. 56th ed. Montvale, NJ: Medical Economics Co, 2002:2803.
38. Bang LM, Easthope SE, Perry CM. Transdermal oxybutynin for overactive bladder. Drugs Aging 2003; 20:857-864.
39. Davila GW, Daugherty CA, Sanders SW. For the Transdermal Oxybutynin Study Group. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. J Urol 2001; 166:140-145.
40. Dmochowski RR, Sand PK, Zinner NR, et al; for the Transdermal Oxybutynin Study Group. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine vs placebo in previously treated patients with urge and mixed urinary incontinence. Urology 2003; 62:237-242.
41. Lin HH, Sheu BC, Lo MC, Huang SC. Comparison of treatment outcomes for imipramine for female genuine stress incontinence. Br J Obstet Gynaecol 1999; 106:1089-1092.
42. Sullivan J, Abrams P. Pharmacological management of incontinence. Eur Urol 1999; 36(suppl 1):89-95.
43. Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003; 2:CD001405.